Age-Dependent Effects of Butyl Benzyl Phthalate Exposure on Lipid Metabolism and Hepatic Fibrosis in Mice

Overview

Journal Cells

Publisher MDPI

Date 2025 Jan 24

PMID 39851554

Authors

Min-Seo Park

Seonhwa Hwang

Hyun-Bon Kang

Minjeong Ha

Juyeon Park

So-Youn Park

Yong-Joo Park

Min-Hi Park

Affiliations

Soon will be listed here.

Abstract

Endocrine-disrupting chemicals (EDCs), including phthalates, have been implicated in the development of non-alcoholic fatty liver disease (NAFLD) and hepatic fibrosis. This study investigates the age-dependent effects of butyl benzyl phthalate (BBP) exposure on lipid metabolism in the livers of young and aged mice. Young (2-month-old) and aged (20-month-old) male C57BL/6 mice were exposed to BBP through drinking water at a dose of 169 μg/kg/day for 6 and 4 months, respectively. Young mice exposed to BBP showed fatty liver, with downregulation of key fatty acid oxidation genes (CPT1A, CPT1B, CPT2, and Acox1) and elevated pro-inflammatory cytokines (TNF-α and IL-6). In contrast, aged mice exhibited hepatic fibrosis, with increased collagen deposition and upregulation of genes related to fibrosis (Acta2, MMP2, TGF-ß1, and Col1a2), cirrhosis (CXCR4, SOX9, DCN, and MFAP4), and cancer (Bcl2, CDKN2a, c-Myc, and Fn1). Overall, these findings emphasize the importance of age when evaluating the risks of EDC exposure, such as BBP. Future research should focus on understanding the molecular mechanisms behind these age-related differences and explore Grem1 and SOCS3 as potential therapeutic targets for treating EDC-induced and age-related liver diseases.

References

Fu X, He J, Zheng D, Yang X, Wang P, Tuo F . Association of endocrine disrupting chemicals levels in serum, environmental risk factors, and hepatic function among 5- to 14-year-old children. Toxicology. 2021; 465:153011. DOI: 10.1016/j.tox.2021.153011. View

Tahri-Joutey M, Andreoletti P, Surapureddi S, Nasser B, Cherkaoui-Malki M, Latruffe N . Mechanisms Mediating the Regulation of Peroxisomal Fatty Acid Beta-Oxidation by PPARα. Int J Mol Sci. 2021; 22(16). PMC: 8396561. DOI: 10.3390/ijms22168969. View

Al-Eryani L, Wahlang B, Falkner K, Guardiola J, Clair H, Prough R . Identification of Environmental Chemicals Associated with the Development of Toxicant-associated Fatty Liver Disease in Rodents. Toxicol Pathol. 2014; 43(4):482-97. PMC: 4501484. DOI: 10.1177/0192623314549960. View

Lu K, Xu W, Wang L, Zhang D, Zhang C, Liu W . Hepatic β-oxidation and regulation of carnitine palmitoyltransferase (CPT) I in blunt snout bream Megalobrama amblycephala fed a high fat diet. PLoS One. 2014; 9(3):e93135. PMC: 3968065. DOI: 10.1371/journal.pone.0093135. View

Trevino L, Katz T . Endocrine Disruptors and Developmental Origins of Nonalcoholic Fatty Liver Disease. Endocrinology. 2017; 159(1):20-31. PMC: 5761605. DOI: 10.1210/en.2017-00887. View

Ema M, Miyawaki E, Hirose A, Kamata E . Decreased anogenital distance and increased incidence of undescended testes in fetuses of rats given monobenzyl phthalate, a major metabolite of butyl benzyl phthalate. Reprod Toxicol. 2003; 17(4):407-12. DOI: 10.1016/s0890-6238(03)00037-6. View

Lee C, Suk F, Twu Y, Liao Y . Long-Term Exposure to Low-Dose Di-(2-ethylhexyl) Phthalate Impairs Cholesterol Metabolism in Hepatic Stellate Cells and Exacerbates Liver Librosis. Int J Environ Res Public Health. 2020; 17(11). PMC: 7312183. DOI: 10.3390/ijerph17113802. View

Hassan W, Ding L, Gao R, Liu J, Shang J . Interleukin-6 signal transduction and its role in hepatic lipid metabolic disorders. Cytokine. 2014; 66(2):133-42. DOI: 10.1016/j.cyto.2013.12.017. View

Das S, Balakrishnan V . Role of cytokines in the pathogenesis of non-alcoholic Fatty liver disease. Indian J Clin Biochem. 2012; 26(2):202-9. PMC: 3107419. DOI: 10.1007/s12291-011-0121-7. View

10.

Piersma A, Verhoef A, Te Biesebeek J, Pieters M, Slob W . Developmental toxicity of butyl benzyl phthalate in the rat using a multiple dose study design. Reprod Toxicol. 2000; 14(5):417-25. DOI: 10.1016/s0890-6238(00)00100-3. View

11.

Ditzel E, Nguyen T, Parker P, Camenisch T . Effects of Arsenite Exposure during Fetal Development on Energy Metabolism and Susceptibility to Diet-Induced Fatty Liver Disease in Male Mice. Environ Health Perspect. 2015; 124(2):201-9. PMC: 4749082. DOI: 10.1289/ehp.1409501. View

12.

Cano R, Perez J, Angarita Davila L, Ortega A, Gomez Y, Valero-Cedeno N . Role of Endocrine-Disrupting Chemicals in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review. Int J Mol Sci. 2021; 22(9). PMC: 8125512. DOI: 10.3390/ijms22094807. View

13.

Lee J, Wada T, Febbraio M, He J, Matsubara T, Lee M . A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosis. Gastroenterology. 2010; 139(2):653-63. PMC: 2910786. DOI: 10.1053/j.gastro.2010.03.033. View

14.

Budick-Harmelin N, Anavi S, Madar Z, Tirosh O . Fatty acids-stress attenuates gluconeogenesis induction and glucose production in primary hepatocytes. Lipids Health Dis. 2012; 11:66. PMC: 3391994. DOI: 10.1186/1476-511X-11-66. View

15.

Yan J, Chen Z, Wang C, Xue Y, Lin L, He C . Analysis of 10 Phthalate Esters in Water-Based Adhesives by Supercritical Fluid Chromatography-Tandem Mass Spectrometry Combined With Spherical Carbons-Based Dispersion Solid-Phase Extraction. J AOAC Int. 2023; 106(4):909-916. DOI: 10.1093/jaoacint/qsad048. View

16.

Pedroso J, Ramos-Lobo A, Donato Jr J . SOCS3 as a future target to treat metabolic disorders. Hormones (Athens). 2018; 18(2):127-136. DOI: 10.1007/s42000-018-0078-5. View

17.

Xu Y, Wu Y, Xiong Y, Tao J, Pan T, Tan S . Ascorbate protects liver from metabolic disorder through inhibition of lipogenesis and suppressor of cytokine signaling 3 (SOCS3). Nutr Metab (Lond). 2020; 17:17. PMC: 7057613. DOI: 10.1186/s12986-020-0431-y. View

18.

Zhang J, Powell C, Kay M, Park M, Meruvu S, Sonkar R . A moderate physiological dose of benzyl butyl phthalate exacerbates the high fat diet-induced diabesity in male mice. Toxicol Res (Camb). 2020; 9(4):353-370. PMC: 7467250. DOI: 10.1093/toxres/tfaa037. View

19.

Brunt E . Pathology of fatty liver disease. Mod Pathol. 2007; 20 Suppl 1:S40-8. DOI: 10.1038/modpathol.3800680. View

20.

Song H, Huang Q, Zhang Y, Shen X . Wheat germ peptide improves glucose metabolism and insulin resistance in HepG2 hepatocytes via regulating SOCS3/IRS1/Akt pathway. Nutr Res. 2023; 120:135-144. DOI: 10.1016/j.nutres.2023.10.005. View